Physician specialty is associated with differences in warfarin use for atrial fibrillation

被引:0
|
作者
Kellen, JC [1 ]
Russell, ML [1 ]
机构
[1] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada
关键词
anticoagulants; atrial fibrillation; mail survey; physician practice patterns; warfarin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To determine whether physician specialty is associated with prescription of warfarin to elderly persons with atrial fibrillation. DESIGN: Cross sectional survey. SETTING: One hundred and thirty-eight randomly selected general practitioners - all 58 internists and all 27 cardiologists in southern Alberta were surveyed by mail. INTERVENTION: Physicians identified their preferred drug for stroke prevention generally and in response to two hypothetical cases. MAIN RESULTS: Response rates were 66% (general practitioners), 76% (internists) and 89% (cardiologists). Specialists (92%) were more likely than general practitioners (76%) to choose warfarin (P=0.007). Findings were similar for questions related to case scenarios; however, the magnitude of differences between specialists and general practitioners was less pronounced. Specialists were more likely (77%) to prescribe warfarin for elderly females than were general practitioners (62%, P=0.08). Similar proportions of specialists (77%) and general practitioners (67%) would prescribe warfarin to elderly males. CONCLUSION: Physician speciality is associated with warfarin prescription for elderly persons with atrial fibrillation.
引用
下载
收藏
页码:365 / 368
页数:4
相关论文
共 50 条
  • [1] Population prevalence of atrial fibrillation and factors associated with use of warfarin
    Murdoch, DL
    Tait, RC
    Wallace, IW
    O'Neill, KF
    Jackson, J
    McMahon, AD
    Rumley, A
    Lowe, GDO
    EUROPEAN HEART JOURNAL, 2003, 24 : 168 - 168
  • [2] Atrial fibrillation: Physician specialty and ICD implant outcome
    Richards L.
    Nature Reviews Cardiology, 2009, 6 (7) : 443 - 443
  • [3] The use of warfarin in veterans with atrial fibrillation
    Bravata D.M.
    Rosenbeck K.
    Kancir S.
    Brass L.M.
    BMC Cardiovascular Disorders, 4 (1)
  • [4] Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs.
    Pradhan, AA
    Levine, MAH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 153 - 153
  • [5] Analysis of direct costs associated with the use of warfarin in patients with atrial fibrillation
    Belousov, Yu. B.
    Yavelov, I. S.
    Belousov, D. Yu.
    Afanasieva, E. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (05) : 561 - 566
  • [6] Warfarin use among patients with atrial fibrillation
    Brass, LM
    Krumholz, HM
    Scinto, JM
    Radford, M
    STROKE, 1997, 28 (12) : 2382 - 2389
  • [7] Mental Illness and Warfarin Use in Atrial Fibrillation
    Walker, Graham A.
    Heidenreich, Paul A.
    Phibbs, Ciaran S.
    Go, Alan S.
    Chiu, Victor Y.
    Schmitt, Susan K.
    Ananth, Lakshmi
    Frayne, Susan M.
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (09): : 617 - 624
  • [8] Warfarin use in Medicare patients with atrial fibrillation
    Bratzler, DW
    Murray, CK
    Moore, LL
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (14) : 1613 - &
  • [9] National use of warfarin in atrial fibrillation: An update
    Stafford, RS
    Singer, DE
    CIRCULATION, 1998, 97 (08) : 825 - 825
  • [10] National patterns of warfarin use in atrial fibrillation
    Stafford, RS
    Singer, DE
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (22) : 2537 - 2541